Bekir Karakılıç
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bekir Karakılıç has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ali Volkan Özlük
Department of Orthopedics and Traumatology Başakşehir Çam and Sakura City Hospital Istanbul Türkiye
1 shared publication - Emin Can Balcı
Department of Orthopedics and Traumatology, Bağcılar Training and Research Hospital, University of Health Sciences, Istanbul 34000, Turkey
1 shared publication - Mehmet Ali Talmaç
Department of Orthopaedics and Traumatology, Başakşehir Çam and Sakura City Hospital, 34480 Istanbul, Türkiye
1 shared publication - Melih Civan
Basaksehir Cam ve Sakura City Hospital
1 shared publication - Yiğit Önaloğlu
Department of Orthopaedics and Traumatology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey
1 shared publication - Ömer Faruk Gümüş
Department of Orthopedics and Traumatology Başakşehir Çam and Sakura City Hospital Istanbul Türkiye
1 shared publication
Latest Publications
- Open Access
- 18 February 2026
- Published by Wiley in International Wound Journal
- Vol. 23 (2) , e70853
Predictors of Reamputation in Patients With Advanced‐Stage Thromboangiitis Obliterans Ulcers: A Retrospective Cohort Study
Thromboangiitis obliterans (TAO) is a rare, tobacco‐associated vasculitis that primarily affects the distal extremities of young males. In advanced stages, it often leads to chronic limb ischemia with ischemic ulceration, culminating in amputation. Data on risk factors for reamputation in this population remain limited. This study aimed to identify clinical, radiological and microbiological predictors of reamputation in patients with TAO‐related foot ulcers undergoing amputation. A retrospective cohort study was conducted on 25 patients (31 limbs) with Fontaine stage IV TAO ulcers who underwent lower extremity amputation between January 2021 and December 2024. Patients were stratified into two groups based on whether they underwent repeat amputation (Group 1) or a single procedure (Group 2). Preoperative magnetic resonance imaging, intraoperative tissue cultures and laboratory data were evaluated. Smoking status, hospitalisation metrics and adjunctive therapies were recorded. Statistical analysis included Mann–Whitney U, Fisher's exact test, ROC curve analysis and multivariate logistic regression. Seventeen limbs required reamputation. Persistent smoking was observed in 100% of Group 1 compared with 58.4% of Group 2 ( p = 0.015). Positive intraoperative cultures were significantly more frequent in Group 1 (64.7% vs. 21.4%; p = 0.029), with all multidrug‐resistant organisms confined to this group. Length of hospital stay was significantly longer in Group 1 (25.2 ± 6.4 vs. 15.8 ± 5.3 days; p = 0.001). ROC analysis identified > 19 days of hospitalisation as a threshold for reamputation risk (AUC = 0.781; p = 0.018). Multivariate analysis identified three independent predictors of reamputation: persistent smoking (OR: 5.2, 95% CI: 1.2–22.8; p = 0.015), positive intraoperative culture (OR: 4.7, 95% CI: 1.1–20.1; p = 0.041), and hospitalisation longer than 19 days (OR: 6.5, 95% CI: 1.4–29.4; p = 0.018). Reamputation in advanced‐stage TAO is strongly associated with modifiable factors, particularly ongoing tobacco use, Gram‐negative infection and prolonged hospital stay. Early identification and targeted intervention addressing these variables may improve limb preservation outcomes in this high‐risk population.
- 18 February 2026
- Published by Wiley in International Wound Journal
- Vol. 23 (2) , e70853
Open AccessPredictors of Reamputation in Patients With Advanced‐Stage Thromboangiitis Obliterans Ulcers: A Retrospective Cohort Study
Thromboangiitis obliterans (TAO) is a rare, tobacco‐associated vasculitis that primarily affects the distal extremities of young males. In advanced stages, it often leads to chronic limb ischemia with ischemic ulceration, culminating in amputation. Data on risk factors for reamputation in this population remain limited. This study aimed to identify clinical, radiological and microbiological predictors of reamputation in patients with TAO‐related foot ulcers undergoing amputation. A retrospective cohort study was conducted on 25 patients (31 limbs) with Fontaine stage IV TAO ulcers who underwent lower extremity amputation between January 2021 and December 2024. Patients were stratified into two groups based on whether they underwent repeat amputation (Group 1) or a single procedure (Group 2). Preoperative magnetic resonance imaging, intraoperative tissue cultures and laboratory data were evaluated. Smoking status, hospitalisation metrics and adjunctive therapies were recorded. Statistical analysis included Mann–Whitney U, Fisher's exact test, ROC curve analysis and multivariate logistic regression. Seventeen limbs required reamputation. Persistent smoking was observed in 100% of Group 1 compared with 58.4% of Group 2 ( p = 0.015). Positive intraoperative cultures were significantly more frequent in Group 1 (64.7% vs. 21.4%; p = 0.029), with all multidrug‐resistant organisms confined to this group. Length of hospital stay was significantly longer in Group 1 (25.2 ± 6.4 vs. 15.8 ± 5.3 days; p = 0.001). ROC analysis identified > 19 days of hospitalisation as a threshold for reamputation risk (AUC = 0.781; p = 0.018). Multivariate analysis identified three independent predictors of reamputation: persistent smoking (OR: 5.2, 95% CI: 1.2–22.8; p = 0.015), positive intraoperative culture (OR: 4.7, 95% CI: 1.1–20.1; p = 0.041), and hospitalisation longer than 19 days (OR: 6.5, 95% CI: 1.4–29.4; p = 0.018). Reamputation in advanced‐stage TAO is strongly associated with modifiable factors, particularly ongoing tobacco use, Gram‐negative infection and prolonged hospital stay. Early identification and targeted intervention addressing these variables may improve limb preservation outcomes in this high‐risk population.